Overview

Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the most sensitive outcome measures (functional or morphological) of a progressive renal injury in patients with IgA nephropathy. II. Determine which of these patients are destined to progress to further injury in order to target them for therapy. III. Elucidate the determinants of progression in those patients who exhibit evidence of either increasing impairment of ultrafiltration capacity or ongoing destruction of nephrons.
Phase:
N/A
Details
Lead Sponsor:
National Center for Research Resources (NCRR)
Collaborator:
Stanford University
Treatments:
Enalapril
Enalaprilat